Variability in immunophenotype in diffuse large B‐cell lymphoma and its clinical relevance
L De Leval, NL Harris - Histopathology, 2003 - Wiley Online Library
Diffuse large B‐cell lymphoma (DLBCL), the single largest category of lymphoma, is a
clinically and biologically heterogeneous disease entity. Clinically, patients differ in their …
clinically and biologically heterogeneous disease entity. Clinically, patients differ in their …
Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms
Abstract The activator protein-1 (AP-1) is a dimeric transcription factor composed of proteins
belonging to the Jun (c-Jun, JunB and JunD), Fos (c-Fos, FosB, Fra1 and Fra2) and …
belonging to the Jun (c-Jun, JunB and JunD), Fos (c-Fos, FosB, Fra1 and Fra2) and …
[HTML][HTML] Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
M Berglund, U Thunberg, RM Amini, M Book, G Roos… - Modern pathology, 2005 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) has been shown to be comprised of at least two
prognostic entities, depending on its resemblance to normal germinal center or activated B …
prognostic entities, depending on its resemblance to normal germinal center or activated B …
Antagonistic interactions in mitochondria ros signaling responses to manganese
Antagonistic interaction refers to opposing beneficial and adverse signaling by a single
agent. Understanding opposing signaling is important because pathologic outcomes can …
agent. Understanding opposing signaling is important because pathologic outcomes can …
[HTML][HTML] CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression
N Bilalovic, B Sandstad, R Golouh, JM Nesland… - Modern Pathology, 2004 - Elsevier
CD10 antigen is a 100-kDa-cell surface zinc metalloendopeptidase expressed in a variety of
normal and neoplastic lymphoid and nonlymphoid tissues including melanomas. It was …
normal and neoplastic lymphoid and nonlymphoid tissues including melanomas. It was …
[图书][B] Flow cytometry of hematological malignancies
C Ortolani - 2021 - books.google.com
Flow Cytometry of Hematological Malignancies Flow cytometric analysis is often integral to
the swift and accurate diagnosis of leukemias and lymphomas of the blood, bone marrow …
the swift and accurate diagnosis of leukemias and lymphomas of the blood, bone marrow …
Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas
X Lu, H Nechushtan, F Ding, MF Rosado, R Singal… - Blood, 2005 - ashpublications.org
Diffuse large B-cell lymphomas (DLBCLs) can be subclassified into germinal center B-cell
(GCB)-like and activated B-cell (ABC)-like tumors characterized by long and short survival …
(GCB)-like and activated B-cell (ABC)-like tumors characterized by long and short survival …
Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue
D Kalogeropoulos, A Papoudou-Bai… - Clinical and …, 2018 - Springer
Ocular adnexal lymphomas are a group of heterogeneous neoplasms representing
approximately 1–2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. The …
approximately 1–2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. The …
Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma
S Hasselblom, B Ridell, M Sigurdardottir… - Leukemia & …, 2008 - Taylor & Francis
The prognostic role of overexpression of Ki-67 protein in diffuse large B-cell lymphoma
(DLBCL) is still unclear. Furthermore, immunohistochemical studies have suggested a …
(DLBCL) is still unclear. Furthermore, immunohistochemical studies have suggested a …
Primary lymphomas of bone
Primary lymphomas of bone are uncommon malignancies. The vast majority of them are non-
Hodgkin lymphoma (NHL), whereas primary Hodgkin lymphoma (HL) of bone is extremely …
Hodgkin lymphoma (NHL), whereas primary Hodgkin lymphoma (HL) of bone is extremely …